A two-site model for antiestrogen action
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 125 (10-11) , 679-682
- https://doi.org/10.1016/j.mad.2004.08.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH) 2 -vitamin D 3 signalingProceedings of the National Academy of Sciences, 2004
- Steroid Hormones, Receptors, and AntagonistsAnnals of the New York Academy of Sciences, 1996
- A New Interpretation of Antiestrogen ActionaAnnals of the New York Academy of Sciences, 1995
- Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding siteMolecular and Cellular Endocrinology, 1994
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cellsBreast Cancer Research and Treatment, 1989
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor.Proceedings of the National Academy of Sciences, 1988
- Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterusBiochemical and Biophysical Research Communications, 1985
- Antagonism of estrogen action with a new benzothiophene derived antiestrogenLife Sciences, 1983